Now Better Searching for Health Professionals

Although a nearly infinite amount of information is nowadays accessible via the Internet, it is not easy to systematically sort out the right information. This problem is addressed by Transinsight GmbH in Dresden, a company that develops knowledge-based search technologies in close cooperation with the Technische Universität Dresden. Now, after a development period of only six months, Transinsight GmbH has created MeSHPubMed, the worldwide first knowledge-based search engine for the medical sciences to be made available on the Internet.

The search platform www.MeSHPubMed.org intelligently searches and, thus, finds the desired results much faster and much more precisely than a standard search engine can. For the first time, the technology for the intelligent search developed by Transinsight GmbH in cooperation with the TU Dresden has been used on the well-known search engine for molecular biologists www.GOPubMed.org.

"Now, medical professionals will be able to work much more efficiently, because they will be able to utilize the search engine MeSHPubMed which sorts the 16 million presently available scientific articles in such a way as is intended by the knowledge network MeSH (Medical Subject Headings), an initiative of the National Library of Medicine, USA," says Dr. Michael R. Alvers, CEO of Transinsight. The search engine allows the search time for relevant scientific information to be drastically reduced. For example, a search for the tumor suppressor protein P53 delivers about 10 million articles through conventional search engines and more than 40,000 articles in the case of standard medical search engines like www.PubMed.org. For the user, it is impossible to browse this quantity of texts. However, with www.MeSHPubMed.org, by means of interactive navigation in the knowledge tree of the MeSH, clicking the hierarchical entries "Diseases" -> "Cardiovascular Diseases" -> "Heart Diseases," means the search results can be restricted so that only six relevant articles are shown. This is a great time saver!

Prof. Dr. Michael Schroeder, co-founder of Transinsight and professor of bioinformatics at the Technische Universität Dresden, is enthused to see the practical use of technologies developed partly within European research projects such as REWERSE, Sealife and EFRE. "We are proud to have developed technologies that reach a speed and precision that currently cannot be achieved by anybody else in the world. Our ultra-fast and very precise algorithms provide an enormous customer benefit: the noticeable shortening of search times! Having already two products online is a good example of a great knowledge transfer between university and industry," says Schroeder.

This fruitful cooperation between Transinsight and the Technische Universität Dresden is based on a cooperation contract. "In Dresden, there is an atmosphere like at Stanford University, at MIT in Boston or at Cambridge University," says Alvers. On this fertile ground, Transinsight GmbH wants to open new horizons. To that end, two new search platforms are already in the beta test. Moreover, with a partner, Transinsight wants to address other areas such as the job search field, because the technology of sorted searching is global and can be used in non-biomedical areas as well.

Related news articles:

About Transinsight
Founded in November 2005, Transinsight is focused on software solutions for the life sciences providing products for knowledge based technologies. The flagship product, GoPubMed, a well established biomedical search engine, was the first knowledge based search engine for the Life Sciences on the Internet. Transinsight is headquartered in one of the leading German biotech incubators, the BioInnovationCenter Dresden BIOZ, where science and business work under one roof. Transinsight works in close collaboration with the Technische Universität Dresden. For further information, visit: http://www.transinsight.com

About REWERSE
The European Network of Excellence REWERSE is a research project on "Reasoning on the Semantic Web". REWERSE develops rule-based languages and applications to intelligently process data on the conventional and the Semantic Web. REWERSE is funded by the European Commission and Switzerland within the 6th Framework Programme, reference number 506779. The project started in March 2004 and runs for four years. REWERSE networks over 100 researches from 27 research and industry organisations in 14 European countries. For further information, visit: http://rewerse.net

Most Popular Now

AI-Powered CRISPR could Lead to Faster G…

Stanford Medicine researchers have developed an artificial intelligence (AI) tool to help scientists better plan gene-editing experiments. The technology, CRISPR-GPT, acts as a gene-editing “copilot” supported by AI to help...

Groundbreaking AI Aims to Speed Lifesavi…

To solve a problem, we have to see it clearly. Whether it’s an infection by a novel virus or memory-stealing plaques forming in the brains of Alzheimer’s patients, visualizing disease processes...

AI Spots Hidden Signs of Depression in S…

Depression is one of the most common mental health challenges, but its early signs are often overlooked. It is often linked to reduced facial expressivity. However, whether mild depression or...

AI Tools Help Predict Severe Asthma Risk…

Mayo Clinic researchers have developed artificial intelligence (AI) tools that help identify which children with asthma face the highest risk of serious asthma exacerbation and acute respiratory infections. The study...

AI Model Forecasts Disease Risk Decades …

Imagine a future where your medical history could help predict what health conditions you might face in the next two decades. Researchers have developed a generative AI model that uses...

AI Model Indicates Four out of Ten Breas…

A project at Lund University in Sweden has trained an AI model to identify breast cancer patients who could be spared from axillary surgery. The model analyses previously unutilised information...

ChatGPT 4o Therapeutic Chatbot 'Ama…

One of the first randomized controlled trials assessing the effectiveness of a large language model (LLM) chatbot 'Amanda' for relationship support shows that a single session of chatbot therapy...

AI Distinguishes Glioblastoma from Look-…

A Harvard Medical School–led research team has developed an AI tool that can reliably tell apart two look-alike cancers found in the brain but with different origins, behaviors, and treatments. The...

Smart Device Uses AI and Bioelectronics …

As a wound heals, it goes through several stages: clotting to stop bleeding, immune system response, scabbing, and scarring. A wearable device called "a-Heal," designed by engineers at the University...

Overcoming the AI Applicability Crisis a…

Opinion Article by Harry Lykostratis, Chief Executive, Open Medical. The government’s 10 Year Health Plan makes a lot of the potential of AI-software to support clinical decision making, improve productivity, and...

Dartford and Gravesham Implements Clinis…

Dartford and Gravesham NHS Trust has taken a significant step towards a more digital future by rolling out electronic test ordering using Clinisys ICE. The trust deployed the order communications...